JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 16, 2005; DOI: 10.1124/jpet.105.092221


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.092221v1
316/1/162    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bito, V.
Right arrow Articles by Sipido, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bito, V.
Right arrow Articles by Sipido, K. R.


Received for publication July 12, 2005.
Revised September 14, 2005.
Accepted for publication September 14, 2005.

The amiodarone derivative, 2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015) induces a Na+-dependent increase of [Ca2+] in ventricular myocytes

Virginie Bito 1, Dieter Dauwe 1, Fons Verdonck 2, Kanigula Mubagwa 3, Karin R. Sipido 1*

1 Laboratory of Experimental Cardiology 2 Interdisciplinary Research Center, KULAK 3 CEHA

* Address correspondence to: E-mail: karin.sipido{at}med.kuleuven.be

Abstract

2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015; KB) is a novel amiodarone derivative designed to retain the antiarrhythmic effects without the side-effects. Unlike amiodarone, KB slows Na+ current inactivation and could, via an increase in [Na+]i, potentially lead to Ca2+ overload. We therefore studied the effects of KB on Na+ and Ca2+ handling in single pig ventricular myocytes using the whole-cell ruptured patch-clamp technique and K5Fluo-3 as [Ca2+]i indicator. KB at 10 µM did not prolong action potential duration, but slightly increased the early plateau; spontaneous afterdepolarizations were not observed. The amplitude of the [Ca2+]i transient was larger (434.9±37.2 nM vs. 326.8±39.8 nM at baseline, n=13, P<0.05) and the time to peak [Ca2+]i was prolonged. During voltage clamp pulses, [Ca2+]i transient peak was also larger (578.1±98.9 nM vs. 346.4±52.6 nM at baseline, P<0.05). Though L-type Ca2+ current was reduced (by 21.9% at +10 mV, n=9, P<0.05), sarcoplasmic reticulum Ca2+ content was significantly enhanced with KB. Forward Na/Ca exchange was significantly decreased after KB application, but reverse-mode of the Na/Ca exchanger was significantly larger, suggesting an increase in [Na+]i with KB. This was confirmed by a two-fold increase of the [Na+]-dependent current generated by the Na/K-ATPase (from 0.17±0.02 to 0.38±0.06 pA/pF, P<0.05). In conclusion, as predicted from the slowing of INa inactivation, KB130015 leads to an increase in [Na+]i and consequently in cellular Ca2+ load. This effect is partially offset by a decrease in ICaL resulting in a mild inotropic effect without the signs of Ca2+ overload and related arrhythmias usually associated with Na+ channel openers.


Key words: L-type Ca2+ current, Na+ current, Na/Ca exchange, afterdepolarizations, arrhythmias, cardiac myocytes


This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Ozdemir, V. Bito, P. Holemans, L. Vinet, J.-J. Mercadier, A. Varro, and K. R. Sipido
Pharmacological Inhibition of Na/Ca Exchange Results in Increased Cellular Ca2+ Load Attributable to the Predominance of Forward Mode Block
Circ. Res., June 6, 2008; 102(11): 1398 - 1405.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.